NCT03186742View on ClinicalTrials.gov

Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

January 1, 2017

Study Completion Date

June 1, 2017

Conditions
Hypertension,EssentialObstructive Sleep ApneaLeft Ventricular Hypertrophy
Interventions
DRUG

Eplerenone 50 mg Tab

Eplerenone 50 mg Tab once a day

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT03186742 - Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy | Biotech Hunter | Biotech Hunter